Newsroom

Home / Newsroom / Positive 48-Week Clinical Data of AlloJoin Human Adipose-Derived Mesenchymal Progenitor Cell (haMPC) Knee Osteoarthritis (KOA) China Phase I Trial
16Mar

Positive 48-Week Clinical Data of AlloJoin Human Adipose-Derived Mesenchymal Progenitor Cell (haMPC) Knee Osteoarthritis (KOA) China Phase I Trial

Download Full Article as .PDF (Size: 161 kB)

This CBMG article was posted on 16 Mar 2018